BioMaxima S.A. (WSE:BMX)
Poland · Delayed Price · Currency is PLN 13.15
+0.15 (1.15%)
Aug 12, 2025, 5:00 PM CET
Acelyrin Market Cap
BioMaxima has a market cap or net worth of 54.51 million as of August 12, 2025. Its market cap has decreased by -22.85% in one year.
Market Cap
54.51M
Enterprise Value
69.45M
Revenue
56.60M
Ranking
n/a
PE Ratio
62.37
Stock Price
$13.15
Market Cap Chart
Since July 21, 2010, BioMaxima's market cap has increased from 11.40M to 54.51M, an increase of 378.01%. That is a compound annual growth rate of 10.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 54.51M | 21.50% |
| Dec 30, 2024 | 44.87M | -34.84% |
| Dec 29, 2023 | 68.85M | -35.28% |
| Dec 30, 2022 | 106.38M | -6.37% |
| Dec 30, 2021 | 113.62M | -4.71% |
| Dec 30, 2020 | 119.23M | 792.90% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.55B |
| NEUCA | 2.96B |
| Voxel | 1.88B |
| Synektik Spólka Akcyjna | 1.77B |
| Celon Pharma | 1.22B |
| Ryvu Therapeutics | 704.01M |
| Selvita | 611.24M |
| Centrum Medyczne ENEL-MED | 562.78M |